GlassScriptPhysician profile
Sheena S Abraham
NPI 1518374115
$4,385.08
in general payments reported to CMS, 2019-2025
43 companies · $808 in 2025
The $808 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $666 · 2022: $976 · 2023: $1,075 · 2024: $861 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,743.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $900.19 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $501.69 | 2021-2025 | Ubrelvy, Vraylar |
| Pfizer INC. | $462.90 | 2023-2025 | |
| Glaxosmithkline, LLC. | $243.93 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Biohaven Pharmaceutical Holding Company LTD. | $230.28 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $221.34 | 2021-2024 | Farxiga, Breztri, Airsupra |
| Astellas Pharma US INC | $164.90 | 2025 | Veozah |
| Itamar Medical INC | $122.94 | 2022-2023 | Watchpatone |
| Inari Medical, INC. | $105.49 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Corium, LLC | $87.98 | 2022-2023 | Azstarys |
| Biohaven Pharmaceuticals, INC. | $87.58 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.84 | 2021-2023 | Trintellix |
| Lilly USA, LLC | $71.63 | 2022-2025 | Jardiance |
| Medtronic, INC. | $71.53 | 2022-2025 | Kyphon Express II Kyphopak Tray, Venaseal |
| Merck Sharp & Dohme LLC | $70.31 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheena Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.